Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Billur Samli"'
Autor:
Daniel Malek, BS, MS, Sebastiano Buccheri, BS, Courtney B. Dey, MD, Billur Samli, MD, John Plemmons, MD
Publikováno v:
Radiology Case Reports, Vol 14, Iss 12, Pp 1500-1505 (2019)
While metastatic disease to the breast has been documented from many primary neoplasms with incidence ranging from 0.2% to approximately 2.7% among reported clinical cases, breast cancer metastases resulting from a primary lung neoplasm is significan
Externí odkaz:
https://doaj.org/article/d5296ca9a7ef4e0b98544798436c82e5
Autor:
Taylor N. Drake, Brandon Euker, Angela M. Tang-Tan, Caroline Dasom Lee, Emily L. Breeding, Janet S. Winston, Billur Samli, Rick J. Jansen, Michael Danso, Mary L. Guye, Richard A. Hoefer, Amy H. Tang
Publikováno v:
Cancer Research. 83:1961-1961
Introduction: Metastatic breast cancer (MBC) is the 2nd leading cause of cancer-related deaths in American women. While improvements in local and systemic therapies have significantly improved survival, 43,250 MBC patients are expected to succumb to
Autor:
Amy H. Tang, Richard A. Hoefer, Dasom Lee, Emily L. Breeding, Mary L. Guye, Janet S. Winston, Billur Samli, Jennifer Koblinski, Valentina Robila, Michael O. Idowu, Rick J. Jansen, Harry D. Bear
Publikováno v:
Cancer Research. 83:5531-5531
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and disproportionately affects BRCA1 mutation carriers and young black women. Black/African American (AA) patients with TNBC have the highest mortality rate and the sho
Publikováno v:
Radiology Case Reports, Vol 14, Iss 12, Pp 1500-1505 (2019)
Radiology Case Reports
Radiology Case Reports
While metastatic disease to the breast has been documented from many primary neoplasms with incidence ranging from 0.2% to approximately 2.7% among reported clinical cases, breast cancer metastases resulting from a primary lung neoplasm is significan
Autor:
Billur Samli, Lauren L. Siewertsz van Reesema, David Z. Chang, Harry D. Bear, Janet S. Winston, Amber L. Collier, Amy H. Tang, Matthew P. Goetz, Richard A. Hoefer, Emanuel F. Petricoin, Rick J. Jansen, Gagan K. Gupta, Vasilena Zheleva, Mary L. Guye, Dasom Lee, Angela M. Tang-Tan
Publikováno v:
Cancers, Vol 12, Iss 2392, p 2392 (2020)
Cancers
Cancers
Triple-negative breast cancer (TNBC), characterized by the absence or low expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER2), is the most aggressive subtype of breast cancer. TNBC accou
Autor:
Alex C. Lafever, Caroline Dasom Lee, Mary L. Guye, Rick J. Jansen, Robert E. Van Sciver, Richard A. Hoefer, Gagan K. Gupta, Amy H. Tang, Janet S. Winston, Billur Samli, Anthony Pang, Michael P. Lee, Angela M. Tang-Tan
Publikováno v:
Annals of breast cancer and therapy
Chemo-resistant breast cancer is a major barrier to curative treatment for a significant number of women with breast cancer. Neoadjuvant chemotherapy (NACT) is standard first- line treatment for most women diagnosed with high-risk TNBC, HER2+, and lo
Publikováno v:
Chest. 160:A1644
Publikováno v:
BJOG: An International Journal of Obstetrics and Gynaecology. 109:121-128
Objective To study the value of creatine kinase in ectopic pregnancy with reference to tubal histopathology. Design Prospective controlled study. Setting Academic tertiary-care institution. Population Thirty-two women with ectopic pregnancy and 20 co
Autor:
Jeanne A. Petrek, N B A Katherine Tran, P. Peter Rosen, Laura Liberman, Billur Samli, Kimberly J. Van Zee, Beryl McCormick, Patrick I. Borgen
Publikováno v:
Cancer. 86:1757-1767
BACKGROUND Although in recent years there has been a dramatic increase in both the incidence of ductal carcinoma in situ (DCIS) and breast-conserving therapy for patients who have this disease, the optimal treatment for these patients remains controv
Autor:
Paul Peter Rosen, Kimberly J. Van Zee, Billur Samli, Katherine N. Tran, Patrick I. Borgen, Eun-Sil Hwang
Publikováno v:
Annals of Surgical Oncology. 5:757-763
The optimal treatment of ductal carcinoma in situ (DCIS) is one of the most controversial issues in the management of breast cancer. Identification of factors that affect the risk of local recurrence is very important as the incidence of DCIS increas